INITIAL TREATMENT OF HEMODYNAMICALLY STABLE
Initial Presentation
Initial Clinical Experience with the HeartMate® II Axial
INITIAL ACTIVATION: SINOATRIAL NODE (SA NODE) SVC
INITIAL
Inhibition of TGF-β1 by eNOS gene transfer provides cardiac
inhibition of pyruvate dehydrogenase kinase decreases the severity
Inhibition of Protein Synthesis in Cardiac Hypertrophy and its
Inhibition of nitric oxide synthase slows heart rate recovery from
Inhibition of MicroRNA-92a Protects Against Ischemia
Inhibition of histone deacetylase on ventricular remodeling in
Inhibition of Dipeptidyl Peptidase-4 Impairs
Inhibition of cyclooxygenase-2 improves cardiac - AJP
Inhibition of Coronary Blood Flow by a Vascular Waterfall Mechanism
Inhibition of 14q32 microRNAs drastically improves blood flow
Inhibition in the human heart
inherited progressive cardiac conduction disorders
Inherited heart disease clinic
Inherited Heart Disease
Inherited heart conditions Sudden arrhythmic death syndrome
